POSSIBLE EXPLANATION FOR COGNITIVE DECLINE IN NORMAL AGING.

-

 

POSSIBLE EXPLANATION FOR COGNITIVE DECLINE IN NORMAL AGING.







Scientists at the University of Colorado Anschutz Medical Campus have discovered what they believe to be the central mechanism behind cognitive decline associated with normal aging.

"The mechanism involves the mis-regulation of a brain protein known as CaMKII which is crucial for memory and learning," said the study's co-senior author Ulli Bayer, Ph.D., professor of pharmacology at the University of Colorado School of Medicine. "This study directly suggests specific pharmacological treatment strategies."

The study was published today in the journal Science Signaling.

Researchers using mouse models found that altering the CaMKII brain protein caused similar cognitive effects as those that happen through normal aging.

Bayer said that aging in mice and humans decreases a process known as S-nitrosylation, the modification of specific brain proteins, including CaMKII.

"The current study now shows a decrease in this modification of CaMKII is sufficient to cause impairments in synaptic plasticity and in memory that are similar in aging," Bayer said.

Normal aging reduces the amount of nitric oxide in the body. The study said that, in turn, reduces nitrosylation, which reduces memory and learning ability.

Bayer said the new research opens the way toward developing drugs and other therapeutic interventions that could normalize the nitrosylation of the protein. He said that holds out the possibility of treating or staving off average cognitive decline for an unknown period.

He pointed out that this would only work in average age-related cognitive decline, not the decline seen in Alzheimer's disease and dementia.

"We know this protein can be targeted," Bayer said. "And we think it could be done pharmacologically. That is the next logical step."

advertisement

Comments

Post a Comment

Popular posts from this blog

B12 MAY HELP PREVENT ALZHEIMER'S DISEASE.

-
Image
  B12 MAY HELP PREVENT ALZHEIMER'S DISEASE. Worms don't wiggle when they have Alzheimer's disease. Yet something helped worms with the disease hold onto their wiggle in Professor Jessica Tanis's lab at the University of Delaware. In solving the mystery, Tanis and her team have yielded new clues into the potential impact of diet on Alzheimer's, the dreaded degenerative brain disease afflicting more than 6 million Americans. A few years ago, Tanis and her team began investigating factors affecting the onset and progression of Alzheimer's disease. They were doing genetic research with  C. elegans , a tiny soil-dwelling worm subject of numerous studies. Expression of amyloid-beta, a toxic protein implicated in Alzheimer's disease, paralyzes worms within 36 hours of reaching adulthood. While the worms in one petri dish in Tanis's lab were rendered completely immobile, the worms of the same age in the adjacent petri dish still had their wiggle, documented as ...
Read more

BACK PAIN: TREATMENTS AND PREVENTION

-
Image
  BACK PAIN: TREATMENTS  AND PREVENTION Your back hurts. Join the club — you're one of millions dealing with this frustrating condition. Maybe it started after a long day at your desk or crept up slowly over the years. Either way, you're looking for answers. Let's cut through the noise and talk about what works. Why Your Back Might Be Complaining Think of your back as that friend who's always trying to tell you something. Sometimes, it's screaming for attention because you've been slouching at your desk for twelve hours straight. Other times, it's protesting your new workout routine without warming up. The usual suspects? Extra weight is significant — every pound you carry stresses your spine. Then there's how we live now: hunched over phones, slumped on couches, sitting for hours on end. Our bodies weren't built for this. But something that might surprise you: your mind has a more significant role in back pain than you'd think. Stress, anxiety, ...
Read more

Diabetes drugs may reduce the risk of Alzheimer’s.

-
Image
    Diabetes drugs may reduce the risk of Alzheimer’s. The study finds people taking the drugs have fewer biomarkers, slower cognitive decline. People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease compared to people with type 2 diabetes who are not taking the drugs and those without diabetes. The new study, published in the August 11, 2021, online issue of  Neurology , the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups. In people with type 2 diabetes, the body no longer efficiently uses insulin to control blood sugar. Dipeptidyl peptidase-4 inhibitors, also known as gliptins, can be prescribed when other diabetes drugs do not work. They help control blood sugar when combined with diet and exercise. "People with diabetes have been shown to ...
Read more